These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 19627190)

  • 1. Innate immune control of nucleic acid-based vaccine immunogenicity.
    Koyama S; Coban C; Aoshi T; Horii T; Akira S; Ishii KJ
    Expert Rev Vaccines; 2009 Aug; 8(8):1099-107. PubMed ID: 19627190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines.
    Ishii KJ; Kawagoe T; Koyama S; Matsui K; Kumar H; Kawai T; Uematsu S; Takeuchi O; Takeshita F; Coban C; Akira S
    Nature; 2008 Feb; 451(7179):725-9. PubMed ID: 18256672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to link innate and adaptive immunity when designing vaccine adjuvants.
    Garlapati S; Facci M; Polewicz M; Strom S; Babiuk LA; Mutwiri G; Hancock RE; Elliott MR; Gerdts V
    Vet Immunol Immunopathol; 2009 Mar; 128(1-3):184-91. PubMed ID: 19042032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond.
    Lahiri A; Das P; Chakravortty D
    Vaccine; 2008 Dec; 26(52):6777-83. PubMed ID: 18835576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants.
    Olive C
    Expert Rev Vaccines; 2012 Feb; 11(2):237-56. PubMed ID: 22309671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The science of adjuvants.
    Kwissa M; Kasturi SP; Pulendran B
    Expert Rev Vaccines; 2007 Oct; 6(5):673-84. PubMed ID: 17931149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunogenicity of viral haemorragic septicaemia rhabdovirus (VHSV) DNA vaccines can depend on plasmid regulatory sequences.
    Chico V; Ortega-Villaizan M; Falco A; Tafalla C; Perez L; Coll JM; Estepa A
    Vaccine; 2009 Mar; 27(13):1938-48. PubMed ID: 19368775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunostimulatory DNA as a vaccine adjuvant.
    Higgins D; Marshall JD; Traquina P; Van Nest G; Livingston BD
    Expert Rev Vaccines; 2007 Oct; 6(5):747-59. PubMed ID: 17931155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular adjuvants for malaria DNA vaccines based on the modulation of host-cell apoptosis.
    Bergmann-Leitner ES; Leitner WW; Duncan EH; Savranskaya T; Angov E
    Vaccine; 2009 Sep; 27(41):5700-8. PubMed ID: 19576940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-like particle vaccines and adjuvants: the HPV paradigm.
    Buonaguro FM; Tornesello ML; Buonaguro L
    Expert Rev Vaccines; 2009 Oct; 8(10):1379-98. PubMed ID: 19803760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII.
    Ramanathan MP; Kutzler MA; Kuo YC; Yan J; Liu H; Shah V; Bawa A; Selling B; Sardesai NY; Kim JJ; Weiner DB
    Vaccine; 2009 Jul; 27(32):4370-80. PubMed ID: 19497647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met as a novel adjuvant for DNA vaccine.
    Lee CG; Choi SY; Park SH; Park KS; Ryu SH; Sung YC
    Vaccine; 2005 Sep; 23(38):4703-10. PubMed ID: 15936851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular detection and immune signaling pathways of DNA vaccines.
    Tang CK; Pietersz GA
    Expert Rev Vaccines; 2009 Sep; 8(9):1161-70. PubMed ID: 19722890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine adjuvants revisited.
    Aguilar JC; Rodríguez EG
    Vaccine; 2007 May; 25(19):3752-62. PubMed ID: 17336431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll or toll-free adjuvant path toward the optimal vaccine development.
    Ishii KJ; Akira S
    J Clin Immunol; 2007 Jul; 27(4):363-71. PubMed ID: 17370119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvants for porcine reproductive and respiratory syndrome virus vaccines.
    Charerntantanakul W
    Vet Immunol Immunopathol; 2009 May; 129(1-2):1-13. PubMed ID: 19157569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccines expressing antigens with a stress protein-capturing domain display enhanced immunogenicity.
    Reimann J; Schirmbeck R
    Immunol Rev; 2004 Jun; 199():54-67. PubMed ID: 15233726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines.
    Wang C; Ge Q; Ting D; Nguyen D; Shen HR; Chen J; Eisen HN; Heller J; Langer R; Putnam D
    Nat Mater; 2004 Mar; 3(3):190-6. PubMed ID: 14991022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG oligonucleotide, host defense peptide and polyphosphazene act synergistically, inducing long-lasting, balanced immune responses in cattle.
    Kovacs-Nolan J; Mapletoft JW; Latimer L; Babiuk LA; Hurk Sv
    Vaccine; 2009 Mar; 27(14):2048-54. PubMed ID: 19428829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic applications of nucleic acids as ligands for Toll-like receptors.
    Panter G; Kuznik A; Jerala R
    Curr Opin Mol Ther; 2009 Apr; 11(2):133-45. PubMed ID: 19330719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.